Published in J Sex Med on January 01, 2010
Oral Contraceptive Therapy and Sexuality (COSEX) | NCT02613039
The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause (2012) 4.04
Sexual activity and satisfaction in healthy community-dwelling older women. Am J Med (2012) 1.70
Management of hypoactive sexual desire disorder in women: current and emerging therapies. Int J Womens Health (2010) 0.86
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function. Eur J Contracept Reprod Health Care (2011) 0.85
Sexual function in women with polycystic ovary syndrome. J Sex Med (2011) 0.84
Challenges in sexual medicine. Nat Rev Urol (2012) 0.77
Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. Womens Health (Lond Engl) (2016) 0.77
Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health (2006) 4.51
Urinary incontinence in young nulligravid women: a cross-sectional analysis. Ann Intern Med (2012) 3.34
Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab (2010) 2.27
Incidence of total knee and hip replacement for osteoarthritis in relation to circulating sex steroid hormone concentrations in women. Arthritis Rheumatol (2014) 2.05
Sexual function after breast cancer. J Sex Med (2010) 1.89
Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging (2013) 1.82
Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med (2005) 1.72
Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years. Menopause (2015) 1.71
Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause (2007) 1.70
Hormone replacement therapy: current controversies. Clin Endocrinol (Oxf) (2003) 1.64
Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause (2003) 1.62
Racial/ethnic differences in the prevalence of depressive symptoms among middle-aged women: The Study of Women's Health Across the Nation (SWAN). Am J Public Health (2004) 1.61
A randomized, controlled pilot study of acupuncture treatment for menopausal hot flashes. Menopause (2008) 1.60
The cross-sectional relationship between fortnightly exercise and knee cartilage properties in healthy adult women in midlife. Menopause (2007) 1.53
Secondary provoked vestibulodynia in sexually active women with uncomplicated recurrent urinary tract infections. J Sex Med (2013) 1.45
Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis. Menopause (2013) 1.41
Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey. Menopause (2015) 1.40
Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women. Menopause (2016) 1.38
A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology (2005) 1.36
Treatment of menopausal symptoms: what shall we do now? Lancet (2005) 1.35
Self-reported sleep in postmenopausal women. Menopause (2004) 1.33
Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women. Horm Behav (2004) 1.33
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur Urol (2004) 1.32
Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab (2006) 1.30
New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab (2003) 1.27
Menopause-associated symptoms and cognitive performance: results from the study of women's health across the nation. Am J Epidemiol (2010) 1.22
Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry (2003) 1.18
Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey. Menopause (2013) 1.14
A qualitative exploration of the cancer experience among long-term survivors: comparisons by cancer type, ethnicity, gender, and age. Psychooncology (2006) 1.11
Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause (2006) 1.09
The North American Menopause Society recommendations for clinical care of midlife women. Menopause (2014) 1.08
Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health (2013) 1.07
Prevalence and incidence of urinary incontinence in women: review of the literature and investigation of methodological issues. Int J Urol (2008) 1.06
Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Clin Endocrinol (Oxf) (2007) 1.06
Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care (2006) 1.05
Sexual function in well women: stratification by sexual satisfaction, hormone use, and menopause status. J Sex Med (2008) 1.05
Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight. J Sex Med (2010) 1.05
Correlates of sexually related personal distress in women with low sexual desire. J Sex Med (2009) 1.03
Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2014) 1.02
Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology (2010) 1.02
Estrogen regulates development of the somatic cell phenotype in the eutherian ovary. FASEB J (2002) 1.00
Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women. Psychosom Med (2002) 1.00
Age-specific prevalence of, and factors associated with, different types of urinary incontinence in community-dwelling Australian women assessed with a validated questionnaire. Maturitas (2009) 1.00
Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause (2005) 0.99
Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev (2004) 0.99
Chronic vulvar and other gynecologic pain: prevalence and characteristics in a self-reported survey. J Reprod Med (2006) 0.98
Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort study. Arthritis Res Ther (2009) 0.98
Sexual function, incontinence, and wellbeing in women after rectal cancer--a review of the evidence. J Sex Med (2012) 0.95
Compartment differences in knee cartilage volume in healthy adults. J Rheumatol (2002) 0.95
DHEA therapy for women: effect on sexual function and wellbeing. Hum Reprod Update (2007) 0.94
Interstitial cystitis is associated with vulvodynia and sexual dysfunction--a case-control study. J Sex Med (2011) 0.94
Urinary incontinence is associated with lower psychological general well-being in community-dwelling women. Menopause (2010) 0.93
Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome. Clin Endocrinol (Oxf) (2011) 0.92
Differential expression of factors involved in fat metabolism with age and the menopause transition. Maturitas (2005) 0.92
Static knee alignment is associated with the risk of unicompartmental knee cartilage defects. J Orthop Res (2008) 0.91
Sexual function in nondepressed women using escitalopram for vasomotor symptoms: a randomized controlled trial. Obstet Gynecol (2012) 0.90
High sensitivity C-reactive protein is associated with lower tibial cartilage volume but not lower patella cartilage volume in healthy women at mid-life. Arthritis Res Ther (2008) 0.89
Greater superior than inferior parietal lobule activation with increasing rotation angle during mental rotation: an fMRI study. Neuropsychologia (2009) 0.89
Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. J Clin Psychiatry (2003) 0.89
Why the product labeling for low-dose vaginal estrogen should be changed. Menopause (2014) 0.88
Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. Menopause (2014) 0.87
Effect of sex and estrogens on neuronal activation in an animal model of migraine. Headache (2012) 0.87
Understanding discontinuation of oral adjuvant endocrine therapy by women with hormone receptor-positive invasive breast cancer nearly 4 years from diagnosis. Menopause (2013) 0.87
Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women. J Womens Health (Larchmt) (2008) 0.86
The natural history of bone marrow lesions in community-based middle-aged women without clinical knee osteoarthritis. Semin Arthritis Rheum (2008) 0.86
Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study. Gynecol Endocrinol (2010) 0.86
Negative beliefs about low back pain are associated with high pain intensity and high level disability in community-based women. BMC Musculoskelet Disord (2008) 0.86
The safety of 52 weeks of oral DHEA therapy for postmenopausal women. Maturitas (2009) 0.86
Reproductive life milestones in women with Parkinson's disease. Funct Neurol (2004) 0.85
Prevalence of fecal incontinence and its relationship with urinary incontinence in women living in the community. Menopause (2011) 0.85
Vaginal DHEA to treat menopause related atrophy: a review of the evidence. Maturitas (2011) 0.85
Menstrual cycle-related changes in circulating androgens in healthy women with self-reported normal sexual function. J Sex Med (2008) 0.85
A pragmatic approach to the classification of menopausal status for community-based research. Menopause (2008) 0.85
Testosterone insufficiency in women: fact or fiction? World J Urol (2002) 0.84
Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40-65 years. Med J Aust (2015) 0.84
The effects of oestrogen on urogenital health. Maturitas (2009) 0.84
The relationship between human semen characteristics and sperm apoptosis: a pilot study. J Androl (2006) 0.84
Distressing sexual problems in United States women revisited: prevalence after accounting for depression. J Clin Psychiatry (2009) 0.84
Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer. BMC Cancer (2008) 0.84
The impact of the mid-urethral slings for the treatment of stress urinary incontinence on female sexuality. J Sex Med (2009) 0.83
Hormonal contraception in women with migraine: is progestogen-only contraception a better choice? J Headache Pain (2013) 0.83
Low back pain and disability in community-based women: prevalence and associated factors. Menopause (2009) 0.83
Transdermal testosterone for women: a new physiological approach for androgen therapy. Obstet Gynecol Surv (2003) 0.83
DHEA for postmenopausal women: a review of the evidence. Maturitas (2010) 0.83
The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer. Fam Cancer (2009) 0.83
Determinants of change in patella cartilage volume in healthy subjects. J Rheumatol (2006) 0.82
The relationship between the knee adduction moment and knee pain in middle-aged women without radiographic osteoarthritis. J Rheumatol (2006) 0.82
Dietary intakes in infertile women a pilot study. Nutr J (2009) 0.82
Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women. Menopause (2013) 0.82
Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. J Sex Med (2008) 0.82
Androgens in women. J Steroid Biochem Mol Biol (2003) 0.82
The prevalence of vitamin D deficiency and relationship with fracture risk in older women presenting in Australian general practice. Australas J Ageing (2011) 0.81
The associations between the dominant and nondominant peak external knee adductor moments during gait in healthy subjects: evidence for symmetry. Arch Phys Med Rehabil (2009) 0.81
Breast cancer survivors' beliefs about the causes of breast cancer. Psychooncology (2011) 0.81
Lymphedema: experience of a cohort of women with breast cancer followed for 4 years after diagnosis in Victoria, Australia. Support Care Cancer (2013) 0.81
Osteoarthritis and the postmenopausal woman: Epidemiological, magnetic resonance imaging, and radiological findings. Semin Arthritis Rheum (2004) 0.81
Androgenic hormones and aging--the link with female sexual function. Horm Behav (2011) 0.81
Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women. Menopause (2003) 0.81